Novel Treatment Targets for Hemophilia A and AML

In this week's episode, Blood editor Dr. James Griffin interviews authors Drs. Vincent Muczynski and Mark Geyer on their latest research published in Blood . Dr. Muczynski's research asks if there could there be a better gene than the factor VIII (FVIII) gene to transfer for curative treatment of hemophilia A? Dr. Geyer then explores CAR T cells armed with interleukin-18 (IL-18) secretion that target CD371, a transmembrane glycoprotein with high expression on AML and leukemia-initiating cells. Both studies explore finding novel targets for these powerful treatment modalities. Featured Articles: Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

You can listen to Novel Treatment Targets for Hemophilia A and AML online on Radio and Podcast. Open the player on this page to stream the available audio.

Novel Treatment Targets for Hemophilia A and AML is an episode from Blood Podcast by American Society of Hematology.

This episode is 23:42 long.

This episode was published on Dec 25, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Blood Podcast when more episodes are available from the podcast feed.